{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:23:41Z","timestamp":1787019821495,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glycodelin is a cell surface glycoprotein offering a unique gender specific carbohydrate configuration. Sialylated carbohydrate structures, which are unusual for mammals, characterize Glycodelin isolated from amniotic fluid (Glycodelin A, GdA). Glycodelin in general exerts multiple, partly opposing functions ranging from immunosuppression to cell differentiation. As these markedly influence tumorigenesis, this study aimed to clarify whether expression of different Glycodelin isoforms is related to clinicopathological characteristics and prognosis of ovarian cancer patients. Further the use of Glycodelin as a serum marker in benign and malignant ovarian diseases was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ovarian cancer specimens (n = 152) were stained for Glycodelin with carbohydrate and peptide specific antibodies. Associations between Glycodelin expression and histological grading, FIGO stage as well as patient\u2019s prognosis were examined. Glycodelin was correlated to expression of gonadotropin receptors and mucin-1, which are discussed as ovarian cancer tissue markers. In addition, Glycodelin serum concentrations were analyzed in patients suffering from benign (n = 73) or malignant (n = 38) ovarian neoplasias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Glycodelin A was found to be an independent prognostic marker for poor prognosis in advanced ovarian cancer patients. GdA staining correlated with gonadotropin receptor (FSHR and LHCGR) and with hCG expression. Gd expression showed a positive correlation with a tumour-associated epitope of mucin 1 (TA-MUC1). Further, compared to ovarian cancer, serum Gd was increased in patients with benign ovarian tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glycodelin A might be related to tumor aggressiveness and poor clinical outcome in advanced epithelial ovarian cancer. Glycodelin serum levels found in patients suffering from benign ovarian tumors, might contribute to a more global attenuation during progression of these precursor lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1756-0500-5-551","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T16:09:35Z","timestamp":1350403775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients"],"prefix":"10.1186","volume":"5","author":[{"given":"Christoph","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Heublein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lenhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"issue":"11","key":"2099_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ejso.2011.08.138","volume":"37","author":"JM Classe","year":"2011","unstructured":"Classe JM, Jaffre I, Frenel JS, Bordes V, Dejode M, Dravet F, Ferron G, Marchal F, Berton Rigaud D, Loussouarn D: Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases. Eur J Surg Oncol. 2011, 37 (11): 971-977. 10.1016\/j.ejso.2011.08.138.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2099_CR2","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002, 20 (5): 1248-1259. 10.1200\/JCO.20.5.1248.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2099_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00404-008-0877-z","volume":"280","author":"SM Lenhard","year":"2009","unstructured":"Lenhard SM, Bufe A, Kumper C, Stieber P, Mayr D, Hertlein L, Kirschenhofer A, Friese K, Burges A: Relapse and survival in early-stage ovarian cancer. Arch Gynecol Obstet. 2009, 280 (1): 71-77. 10.1007\/s00404-008-0877-z.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2099_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jri.2011.04.007","volume":"90","author":"CL Lee","year":"2011","unstructured":"Lee CL, Lam KK, Koistinen H, Seppala M, Kurpisz M, Fernandez N, Pang RT, Yeung WS, Chiu PC: Glycodelin-A as a paracrine regulator in early pregnancy. J Reprod Immunol. 2011, 90 (1): 29-34. 10.1016\/j.jri.2011.04.007.","journal-title":"J Reprod Immunol"},{"issue":"6B","key":"2099_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1582-4934.2009.00922.x","volume":"14","author":"S Ren","year":"2010","unstructured":"Ren S, Liu S, Howell PM, Zhang G, Pannell L, Samant R, Shevde-Samant L, Tucker JA, Fodstad O, Riker AI: Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med. 2010, 14 (6B): 1432-1442.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2099_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1600-0897.2008.00647.x","volume":"60","author":"C Scholz","year":"2008","unstructured":"Scholz C, Toth B, Brunnhuber R, Rampf E, Weissenbacher T, Santoso L, Friese K, Jeschke U: Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am J Reprod Immunol. 2008, 60 (6): 501-512. 10.1111\/j.1600-0897.2008.00647.x.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2099_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jri.2009.10.012","volume":"85","author":"U Jeschke","year":"2010","unstructured":"Jeschke U, Toth B, Scholz C, Friese K, Makrigiannakis A: Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. J Reprod Immunol. 2010, 85 (1): 99-105. 10.1016\/j.jri.2009.10.012.","journal-title":"J Reprod Immunol"},{"issue":"11","key":"2099_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3109\/09513590903159680","volume":"25","author":"B Scholl","year":"2009","unstructured":"Scholl B, Bersinger NA, Kuhn A, Mueller MD: Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Gynecol Endocrinol. 2009, 25 (11): 701-706. 10.3109\/09513590903159680.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"2099_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/00016340903294264","volume":"88","author":"NA Bersinger","year":"2009","unstructured":"Bersinger NA, Birkhauser MH, Yared M, Wunder DM: Serum glycodelin pattern during the menstrual cycle in healthy young women. Acta Obstet Gynecol Scand. 2009, 88 (11): 1215-1221. 10.3109\/00016340903294264.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2099_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/00365510903056023","volume":"69","author":"H Koistinen","year":"2009","unstructured":"Koistinen H, Hautala LC, Seppala M, Stenman UH, Laakkonen P, Koistinen R: The role of glycodelin in cell differentiation and tumor growth. Scand J Clin Lab Invest. 2009, 69 (4): 452-459. 10.1080\/00365510903056023.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"2099_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/CJI.0b013e3181a59fa9","volume":"32","author":"C Scholz","year":"2009","unstructured":"Scholz C, Rampf E, Toth B, Brunnhuber R, Weissenbacher T, Friese K, Jeschke U: Ovarian cancer-derived glycodelin impairs in vitro dendritic cell maturation. J Immunother. 2009, 32 (5): 492-497. 10.1097\/CJI.0b013e3181a59fa9.","journal-title":"J Immunother"},{"key":"2099_CR12","first-page":"67","volume":"4","author":"H Bohn","year":"1982","unstructured":"Bohn H, Kraus W, Winckler W: New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl. 1982, 4: 67-81.","journal-title":"Placenta Suppl"},{"issue":"10","key":"2099_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/molehr\/2.10.759","volume":"2","author":"H Koistinen","year":"1996","unstructured":"Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF, Seppala M: Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod. 1996, 2 (10): 759-765. 10.1093\/molehr\/2.10.759.","journal-title":"Mol Hum Reprod"},{"issue":"3A","key":"2099_CR14","first-page":"1581","volume":"25","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Bischof A, Speer R, Briese V, Richter DU, Bergemann C, Mylonas I, Shabani N, Friese K, Karsten U: Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. Anticancer Res. 2005, 25 (3A): 1581-1589.","journal-title":"Anticancer Res"},{"issue":"4","key":"2099_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2559.2006.02351.x","volume":"48","author":"U Jeschke","year":"2006","unstructured":"Jeschke U, Kuhn C, Mylonas I, Schulze S, Friese K, Mayr D, Speer R, Briese V, Richter DU, Haase M: Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Histopathology. 2006, 48 (4): 394-406. 10.1111\/j.1365-2559.2006.02351.x.","journal-title":"Histopathology"},{"issue":"3","key":"2099_CR16","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE: [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe. 1987, 8 (3): 138-140.","journal-title":"Pathologe"},{"issue":"6","key":"2099_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2559.2011.03848.x","volume":"58","author":"M Lenhard","year":"2011","unstructured":"Lenhard M, Lennerova T, Ditsch N, Kahlert S, Friese K, Mayr D, Jeschke U: Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival. Histopathology. 2011, 58 (6): 990-994. 10.1111\/j.1365-2559.2011.03848.x.","journal-title":"Histopathology"},{"issue":"1","key":"2099_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2407-12-2","volume":"12","author":"M Lenhard","year":"2012","unstructured":"Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D, Friese K, Jeschke U: Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer. 2012, 12 (1): 2-10.1186\/1471-2407-12-2.","journal-title":"BMC Cancer"},{"issue":"1","key":"2099_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-010-1065-y","volume":"128","author":"LC Hautala","year":"2011","unstructured":"Hautala LC, Greco D, Koistinen R, Heikkinen T, Heikkila P, Aittomaki K, Blomqvist C, Koistinen H, Nevanlinna H: Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1\/2 breast cancer patients. Breast Cancer Res Treat. 2011, 128 (1): 85-95. 10.1007\/s10549-010-1065-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"2099_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.acthis.2010.11.009","volume":"113","author":"C Kunert-Keil","year":"2011","unstructured":"Kunert-Keil C, Steinmuller F, Jeschke U, Gredes T, Gedrange T: Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma. Acta Histochem. 2011, 113 (8): 798-802. 10.1016\/j.acthis.2010.11.009.","journal-title":"Acta Histochem"},{"issue":"19","key":"2099_CR21","first-page":"6258","volume":"63","author":"E Mandelin","year":"2003","unstructured":"Mandelin E, Lassus H, Seppala M, Leminen A, Gustafsson JA, Cheng G, Butzow R, Koistinen R: Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res. 2003, 63 (19): 6258-6264.","journal-title":"Cancer Res"},{"issue":"41","key":"2099_CR22","doi-asserted-by":"publisher","first-page":"24116","DOI":"10.1074\/jbc.270.41.24116","volume":"270","author":"A Dell","year":"1995","unstructured":"Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark GF: Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 1995, 270 (41): 24116-24126. 10.1074\/jbc.270.41.24116.","journal-title":"J Biol Chem"},{"issue":"2","key":"2099_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00418-008-0510-z","volume":"131","author":"U Jeschke","year":"2009","unstructured":"Jeschke U, Mylonas I, Kunert-Keil C, Stahn R, Scholz C, Janni W, Kuhn C, Schroder E, Mayr D, Friese K: Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Histochem Cell Biol. 2009, 131 (2): 283-295. 10.1007\/s00418-008-0510-z.","journal-title":"Histochem Cell Biol"},{"issue":"12","key":"2099_CR24","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1111\/j.1582-4934.2009.00911.x","volume":"14","author":"C Napoletano","year":"2010","unstructured":"Napoletano C, Bellati F, Landi R, Pauselli S, Marchetti C, Visconti V, Sale P, Liberati M, Rughetti A, Frati L: Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression. J Cell Mol Med. 2010, 14 (12): 2748-2759. 10.1111\/j.1582-4934.2009.00911.x.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2099_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/gyno.1999.5628","volume":"76","author":"W Zheng","year":"2000","unstructured":"Zheng W, Lu JJ, Luo F, Zheng Y, Feng Y, Felix JC, Lauchlan SC, Pike MC: Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol. 2000, 76 (1): 80-88. 10.1006\/gyno.1999.5628.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"2099_CR26","first-page":"2764","volume":"6","author":"T Minegishi","year":"2000","unstructured":"Minegishi T, Kameda T, Hirakawa T, Abe K, Tano M, Ibuki Y: Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Clin Cancer Res. 2000, 6 (7): 2764-2770.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2099_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1369\/jhc.2008.950600","volume":"56","author":"B Toth","year":"2008","unstructured":"Toth B, Roth K, Kunert-Keil C, Scholz C, Schulze S, Mylonas I, Friese K, Jeschke U: Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy. J Histochem Cytochem. 2008, 56 (5): 477-485. 10.1369\/jhc.2008.950600.","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"2099_CR28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1515\/JPM.2005.039","volume":"33","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, Mylonas I, Friese K: Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J Perinat Med. 2005, 33 (3): 212-218.","journal-title":"J Perinat Med"},{"issue":"5","key":"2099_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000209280","volume":"32","author":"D Dian","year":"2009","unstructured":"Dian D, Janni W, Kuhn C, Mayr D, Karsten U, Mylonas I, Friese K, Jeschke U: Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Onkologie. 2009, 32 (5): 238-244. 10.1159\/000209280.","journal-title":"Onkologie"},{"issue":"1","key":"2099_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/molehr\/gag008","volume":"9","author":"RC Jaffe","year":"2003","unstructured":"Jaffe RC, Donnelly KM, Fazleabas AT: The induction of baboon glycodelin expression by progesterone is not through Sp1. Mol Hum Reprod. 2003, 9 (1): 35-40. 10.1093\/molehr\/gag008.","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"2099_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1525-1438.2001.01017.x","volume":"11","author":"IR Horowitz","year":"2001","unstructured":"Horowitz IR, Cho C, Song M, Flowers LC, Santanam N, Parthasarathy S, Ramachandran S: Increased glycodelin levels in gynecological malignancies. Int J Gynecol Cancer. 2001, 11 (3): 173-179. 10.1046\/j.1525-1438.2001.01017.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"4A","key":"2099_CR32","first-page":"2023","volume":"27","author":"C Richter","year":"2007","unstructured":"Richter C, Baetje M, Bischof A, Makovitzky J, Richter DU, Gerber B, Briese V: Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients. Anticancer Res. 2007, 27 (4A): 2023-2025.","journal-title":"Anticancer Res"},{"issue":"3","key":"2099_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00292-007-0910-1","volume":"28","author":"A Staebler","year":"2007","unstructured":"Staebler A, Diebold J: [Molecular pathology of epithelial ovarian neoplasias: from the phenotype-genotype correlation to new targets in diagnostics and therapy]. Pathologe. 2007, 28 (3): 180-186. 10.1007\/s00292-007-0910-1.","journal-title":"Pathologe"},{"issue":"2","key":"2099_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11845-007-0019-9","volume":"176","author":"EE Lang","year":"2007","unstructured":"Lang EE, Venkatraman G: Glycodelin gene expression in human peripheral white blood cells. Ir J Med Sci. 2007, 176 (2): 101-104. 10.1007\/s11845-007-0019-9.","journal-title":"Ir J Med Sci"},{"issue":"4","key":"2099_CR35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0015-0282(16)57483-4","volume":"63","author":"M Tulppala","year":"1995","unstructured":"Tulppala M, Julkunen M, Tiitinen A, Stenman UH, Seppala M: Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril. 1995, 63 (4): 792-795.","journal-title":"Fertil Steril"},{"issue":"11","key":"2099_CR36","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1093\/humrep\/13.11.3197","volume":"13","author":"CF Dalton","year":"1998","unstructured":"Dalton CF, Laird SM, Estdale SE, Saravelos HG, Li TC: Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome. Hum Reprod. 1998, 13 (11): 3197-3202. 10.1093\/humrep\/13.11.3197.","journal-title":"Hum Reprod"},{"issue":"1","key":"2099_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-0420.2006.00766.x","volume":"85","author":"S Loukovaara","year":"2007","unstructured":"Loukovaara S, Immonen IR, Loukovaara MJ, Koistinen R, Kaaja RJ: Glycodelin: a novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy. Acta Ophthalmol Scand. 2007, 85 (1): 46-49.","journal-title":"Acta Ophthalmol Scand"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:41:21Z","timestamp":1630521681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-551","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]},"assertion":[{"value":"26 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"551"}}